Clinical Trials in Atlanta

Showing 4561-4580 of 19,805 trials

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

NCT06094478

Most stroke patients are initially evaluated at the closest hospital but some need to be transferred to a hospital that can provide more advanced care. The "Door-In-Door-Out" (DIDO) process at the first hospital can take time making transferred patients no longer able to get the advanced treatments. This study will help hospitals across the US "stand up" new ways to evaluate stroke patients, decide who needs to be transferred, and transfer them quickly for advanced treatment.

Stroke, AcuteIschemic Stroke, AcuteHemorrhagic Stroke

University of Chicago900 participantsStarted Oct 2024

New Haven, Connecticut, United States • Miami, Florida, United States • Atlanta, Georgia, United States +4 more locations

RECRUITINGPhase 2< 1 mile

Study of JK07 in Patients With Chronic Heart Failure

NCT06369298

This is a Phase 2, randomized, double-blind, placebo-controlled, multiple dose study to assess the safety, tolerability, and efficacy of JK07 in participants aged 18-85 with heart failure. There will be 2 cohorts in this study: Cohort 1: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) of ≤ 40%. Cohort 2: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) \> 40% and ≤ 65%.

Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction

Salubris Biotherapeutics Inc282 participantsStarted Mar 2024

Alexander City, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +59 more locations

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

Study of JK07 in Patients With Chronic Heart Failure

Find Trials by Condition in Atlanta

Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

Families Left Behind

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis

CCT-102 or Expectant Management in Delayed Pregnancy Loss

A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

ERG Components in Schizophrenia and Bipolar Disorder Type I

HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study